Berrin Pehlivan

専門分野: Radiation oncologist
26年の経験
勤務先: トルコ, Turkey, BP Klinik
- Radiation Oncology specialist at BP Klinik, listed on the clinic’s “Our Team” and “About Us” pages.
- Graduated from Hacettepe University in 2000 and completed her specialty there the same year, then worked in France and Switzerland for 4.5 years.
- Authored international peer-reviewed articles in 2022–2023, including work on radiation-induced trismus risk in parotid gland cancer and predictors of osteoradionecrosis risk in locally advanced nasopharyngeal cancer.
- Has an active academic publication record across radiation oncology topics, with multiple papers listed by the clinic.
Prof. Dr. Berrin Pehlivan is a Radiation Oncology specialist at BP Klinik. She graduated and completed specialty training at Hacettepe University in 2000, then gained 4.5 years of radiation oncology experience in France and Switzerland. Her peer-reviewed publications (including 2022–2023 research on radiation-related complications) reflect a focus on clinically actionable risk prediction in cancer radiotherapy.

医師のサービス

放射線治療

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Prof. Dr. Berrin Pehlivan’s work in radiation oncology includes research on predicting radiation-induced trismus in parotid gland cancer and osteoradionecrosis risk in locally advanced nasopharyngeal cancer. At BP Klinik, she serves as a Radiation Oncology specialist and is presented on both the clinic’s “Our Team” and “About Us” pages. Her training began at Hacettepe University, where she graduated in 2000 and completed her specialty there. After returning to Turkey, she completed an MBA (year not specified in the clinic materials). Before that, she spent 4.5 years working in France and Switzerland, building international clinical experience in radiation oncology.

Education

2000 — Hacettepe University, Medical degree (graduation).
2000 — Hacettepe University, Specialty training in Radiation Oncology.

Work experience

2000-2004.5 — Worked in France and Switzerland (Radiation Oncology).
Current — Prof. Dr. Berrin Pehlivan, Radiation Oncology, BP Klinik.

Clinical focus and techniques

Her clinical and scientific profile centers on radiation oncology and on how treatment variables and patient factors influence radiation-related outcomes.

Radiotherapy / Radiation therapy for oncology patients.

Professional societies and certifications

Not listed in the clinic materials provided.

Academic output

BP Klinik lists multiple international peer-reviewed publications authored by Pehlivan B, including studies published in 2022–2023.

2023 — “Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients,” Eur Arch Otorhinolaryngol.
2022 — “Initial neutrophil-to-lymphocyte ratio predicts radiation-induced trismus in parotid gland cancer,” Oral Diseases.
2022 — “Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy,” Oral Diseases.
2023 — “The prognostic value of the novel global immune-nutrition-inflammation index (GINI) in stage IIIC non-small cell lung cancer patients treated with concurrent chemoradiotherapy,” Cancers (Basel).

Awards and recognition

Not listed in the clinic materials provided.

For international patients, BP Klinik presents its team within a personalized oncology approach. The clinic’s materials emphasize helping patients through the treatment journey with a holistic view that includes quality of life alongside scientific cancer care. Contact details are provided by the clinic for questions and scheduling.